These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 27665293)

  • 1. An RCT into the effects of neurofeedback on neurocognitive functioning compared to stimulant medication and physical activity in children with ADHD.
    Geladé K; Bink M; Janssen TW; van Mourik R; Maras A; Oosterlaan J
    Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):457-468. PubMed ID: 27665293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 6-month follow-up of an RCT on behavioral and neurocognitive effects of neurofeedback in children with ADHD.
    Geladé K; Janssen TWP; Bink M; Twisk JWR; van Mourik R; Maras A; Oosterlaan J
    Eur Child Adolesc Psychiatry; 2018 May; 27(5):581-593. PubMed ID: 29098467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Controlled Trial Investigating the Effects of Neurofeedback, Methylphenidate, and Physical Activity on Event-Related Potentials in Children with Attention-Deficit/Hyperactivity Disorder.
    Janssen TW; Bink M; Geladé K; van Mourik R; Maras A; Oosterlaan J
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):344-53. PubMed ID: 26771913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral Effects of Neurofeedback Compared to Stimulants and Physical Activity in Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial.
    Geladé K; Janssen TW; Bink M; van Mourik R; Maras A; Oosterlaan J
    J Clin Psychiatry; 2016 Oct; 77(10):e1270-e1277. PubMed ID: 27631143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial into the effects of neurofeedback, methylphenidate, and physical activity on EEG power spectra in children with ADHD.
    Janssen TW; Bink M; Geladé K; van Mourik R; Maras A; Oosterlaan J
    J Child Psychol Psychiatry; 2016 May; 57(5):633-44. PubMed ID: 26748531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive effects of neurofeedback in adolescents with ADHD: a randomized controlled trial.
    Bink M; van Nieuwenhuizen C; Popma A; Bongers IL; van Boxtel GJ
    J Clin Psychiatry; 2014 May; 75(5):535-42. PubMed ID: 24922488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of theta/beta neurofeedback on EEG power spectra in children with attention deficit hyperactivity disorder.
    Janssen TWP; Geladé K; Bink M; van Mourik R; Twisk JWR; Maras A; Oosterlaan J
    Clin Neurophysiol; 2020 Jun; 131(6):1332-1341. PubMed ID: 32304847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of neurofeedback versus medication for attention-deficit/hyperactivity disorder.
    Sudnawa KK; Chirdkiatgumchai V; Ruangdaraganon N; Khongkhatithum C; Udomsubpayakul U; Jirayucharoensak S; Israsena P
    Pediatr Int; 2018 Sep; 60(9):828-834. PubMed ID: 29931709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM; Coghill DR; Matthews K
    J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of frequency-neurofeedback and Cogmed JM-working memory training in children with ADHD].
    van Dongen-Boomsma M; Vollebregt MA; Slaats-Willemse D; Buitelaar JK
    Tijdschr Psychiatr; 2015; 57(7):508-16. PubMed ID: 26189419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do stimulant treatments for ADHD work? Evidence for mediation by improved cognition.
    Hawk LW; Fosco WD; Colder CR; Waxmonsky JG; Pelham WE; Rosch KS
    J Child Psychol Psychiatry; 2018 Dec; 59(12):1271-1281. PubMed ID: 29733106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.
    Wigal SB; Wigal T; Schuck S; Brams M; Williamson D; Armstrong RB; Starr HL
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):121-31. PubMed ID: 21488750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofeedback and standard pharmacological intervention in ADHD: a randomized controlled trial with six-month follow-up.
    Meisel V; Servera M; Garcia-Banda G; Cardo E; Moreno I
    Biol Psychol; 2013 Sep; 94(1):12-21. PubMed ID: 23665196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does EEG-neurofeedback improve neurocognitive functioning in children with attention-deficit/hyperactivity disorder? A systematic review and a double-blind placebo-controlled study.
    Vollebregt MA; van Dongen-Boomsma M; Buitelaar JK; Slaats-Willemse D
    J Child Psychol Psychiatry; 2014 May; 55(5):460-72. PubMed ID: 24168522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interactive effects of test-retest and methylphenidate administration on cognitive performance in youth with ADHD: A double-blind placebo-controlled crossover study.
    Horowitz I; Avirame K; Naim-Feil J; Rubinson M; Moses E; Gothelf D; Levit-Binnun N
    Psychiatry Res; 2020 Sep; 291():113056. PubMed ID: 32554183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal treatment in children and adolescents with attention-deficit/hyperactivity disorder: a 6-month follow-up.
    Duric NS; Assmus J; Gundersen D; Duric Golos A; Elgen IB
    Nord J Psychiatry; 2017 Jul; 71(5):386-394. PubMed ID: 28345387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status.
    Huang YS; Wang LJ; Chen CK
    BMC Psychiatry; 2012 Nov; 12():194. PubMed ID: 23140464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD.
    Bioulac S; Purper-Ouakil D; Ros T; Blasco-Fontecilla H; Prats M; Mayaud L; Brandeis D
    BMC Psychiatry; 2019 Aug; 19(1):237. PubMed ID: 31370811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.